1. Home
  2. CDT vs BBLG Comparison

CDT vs BBLG Comparison

Compare CDT & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CDT

Conduit Pharmaceuticals Inc.

N/A

Current Price

$2.46

Market Cap

22.1M

Sector

Health Care

ML Signal

N/A

BBLG

Bone Biologics Corp

N/A

Current Price

$1.32

Market Cap

2.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDT
BBLG
Founded
2019
2004
Country
United States
United States
Employees
6
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.1M
2.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CDT
BBLG
Price
$2.46
$1.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
83.2K
9.6K
Earning Date
04-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$0.66
52 Week High
$11.00
$5.98

Technical Indicators

Market Signals
Indicator
CDT
BBLG
Relative Strength Index (RSI) 44.23 53.04
Support Level $0.66 $1.30
Resistance Level $2.48 $1.36
Average True Range (ATR) 0.69 0.04
MACD -0.34 0.01
Stochastic Oscillator 2.08 47.96

Price Performance

Historical Comparison
CDT
BBLG

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. The company has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The group is committed to creating shareholder value through licensing, strategic M&A, and positioning the company as a platform for transformative innovation.

About BBLG Bone Biologics Corp

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

Share on Social Networks: